AU2001269263A1 - Medicaments containing dextrin for treating respiratory disorders such as cysticfibrosis - Google Patents

Medicaments containing dextrin for treating respiratory disorders such as cysticfibrosis

Info

Publication number
AU2001269263A1
AU2001269263A1 AU2001269263A AU6926301A AU2001269263A1 AU 2001269263 A1 AU2001269263 A1 AU 2001269263A1 AU 2001269263 A AU2001269263 A AU 2001269263A AU 6926301 A AU6926301 A AU 6926301A AU 2001269263 A1 AU2001269263 A1 AU 2001269263A1
Authority
AU
Australia
Prior art keywords
cysticfibrosis
respiratory disorders
medicaments containing
treating respiratory
containing dextrin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001269263A
Inventor
Eric Alton
Myra Stern
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Innovata Biomed Ltd
Original Assignee
Innovata Biomed Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0016133A external-priority patent/GB0016133D0/en
Priority claimed from GB0101414A external-priority patent/GB0101414D0/en
Application filed by Innovata Biomed Ltd filed Critical Innovata Biomed Ltd
Publication of AU2001269263A1 publication Critical patent/AU2001269263A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/718—Starch or degraded starch, e.g. amylose, amylopectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU2001269263A 2000-07-01 2001-07-02 Medicaments containing dextrin for treating respiratory disorders such as cysticfibrosis Abandoned AU2001269263A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0016133 2000-07-01
GB0016133A GB0016133D0 (en) 2000-07-01 2000-07-01 Medicaments
GB0101414 2001-01-19
GB0101414A GB0101414D0 (en) 2001-01-19 2001-01-19 Medicaments
PCT/GB2001/002887 WO2002002126A1 (en) 2000-07-01 2001-07-02 Medicaments containing dextrin for treating respiratory disorders such as cystic fibrosis

Publications (1)

Publication Number Publication Date
AU2001269263A1 true AU2001269263A1 (en) 2002-01-14

Family

ID=26244575

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001269263A Abandoned AU2001269263A1 (en) 2000-07-01 2001-07-02 Medicaments containing dextrin for treating respiratory disorders such as cysticfibrosis

Country Status (2)

Country Link
AU (1) AU2001269263A1 (en)
WO (1) WO2002002126A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040131662A1 (en) 2003-11-12 2004-07-08 Davidson Robert S. Method and apparatus for minimizing heat, moisture, and shear damage to medicants and other compositions during incorporation of same with edible films
US20040191302A1 (en) 2003-03-28 2004-09-30 Davidson Robert S. Method and apparatus for minimizing heat, moisture, and shear damage to medicants and other compositions during incorporation of same with edible films
US8999372B2 (en) 2002-11-14 2015-04-07 Cure Pharmaceutical Corporation Methods for modulating dissolution, bioavailability, bioequivalence and drug delivery profile of thin film drug delivery systems, controlled-release thin film dosage formats, and methods for their manufacture and use
US9561182B2 (en) 2003-08-22 2017-02-07 Cure Pharmaceutical Corporation Edible films for administration of medicaments to animals, methods for their manufacture and methods for their use for the treatment of animals

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4673633A (en) * 1984-06-28 1987-06-16 Cooperbiomedical, Inc. Method of determining cystic fibrosis ciliostatic factor
CN1116053A (en) * 1994-08-03 1996-02-07 谭润光 Candy for relieving tabacco action and producing method thereof
CA2209342A1 (en) * 1997-06-30 1998-12-30 The University Of British Columbia Use of dextran and other oligomeric saccharides to improve airway clearance
GB9806462D0 (en) * 1998-03-26 1998-05-27 Glaxo Group Ltd Improved compositions for inhalation

Also Published As

Publication number Publication date
WO2002002126A1 (en) 2002-01-10

Similar Documents

Publication Publication Date Title
AU4714601A (en) Respiratory nasal filter
AU7859800A (en) Topical nasal treatment
AU2002219173A1 (en) Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use
WO2002030409A8 (en) Methods for the treatment of a traumatic central nervous system injury
HUP0203766A3 (en) 5-pyridyl-1,3-azole compounds, process for producing the same and use thereof and pharmaceutical compositions containing them
AU2002231688A1 (en) Diphenyl azetidinone derivatives, method for the production thereof, medicaments containing these compounds, and their use
AU2001253265A1 (en) Oral treatment systems
AU7085900A (en) Airway treatment apparatus
HUP0401081A3 (en) Novel 1,2-diphenzylazetidinones, method for producing the same, medicaments containing said compounds, and their use
AU2002222118A1 (en) Pharmaceutical compositions for inhalation
IL161446A0 (en) Medicinal compositions for nasal absorption
AU2000272858A1 (en) Pharmaceutical composition for treating hyperhomocysteinaemia caused by medicaments
AU2001293891A1 (en) New combination for the treatment of asthma
AU2002218439A1 (en) Apparatus for treating body ailments
AU2002215114A1 (en) Pharmaceutical compositions for inhalation
AU3945501A (en) Apparatus for dosage of medicaments
AU2001269263A1 (en) Medicaments containing dextrin for treating respiratory disorders such as cysticfibrosis
AU2003205898A1 (en) Combination therapy for respiratory disorders
AU8339301A (en) Compounds for the treatment of addictive disorders
AU2002225327A1 (en) Apparatus for aesthetic treatment
AU5245600A (en) Medicinal compositions for treating lower uropathy
AU2001267135A1 (en) Medicaments
AU2001233706A1 (en) Container for medicaments
ZA991786B (en) Therapeutic treatment for asthma.
AU2001260281A1 (en) Medicament for combating respiratory depression